An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD)-Reference-Cited by-同舟云学术

An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD)

Published:2024-05-09 Issue: Volume: Page:
ISSN:1867-1306
Container-title:Probiotics and Antimicrobial Proteins
language:en
Short-container-title:Probiotics & Antimicro. Prot.

Author:

Yang Lingshuang,Wu Yuwei,Zhao Xinyu,Liang Tingting,Li Longyan,Yang Juan,Jiang Tong,Zhang Tiantian,Zhang Jumei,Zhong Haojie,Xie Xinqiang,Wu Qingping

Funder

Key Laboratory of Guangdong Province

the GDAS Special Project of Capacity Building for Innovation-driven Development

Project by the Department of Science and Technology of Guangdong Province

the Project of National Key Research and Development

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12602-024-10267-7.pdf

Reference52 articles.

1. Alard J, Lehrter V, Rhimi M, Mangin I, Peucelle V, Abraham AL, Mariadassou M et al (2016) Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ Microbiol 18(5):1484–1497. https://doi.org/10.1111/1462-2920.13181

2. Wirtz PH, von Kanel R (2017) Psychological stress, inflammation, and coronary heart disease. Curr Cardiol Rep 19(11):111. https://doi.org/10.1007/s11886-017-0919-x

3. Almeida SO, Budoff M (2019) Effect of statins on atherosclerotic plaque. Trends Cardiovasc Med 29(8):451–455. https://doi.org/10.1016/j.tcm.2019.01.001

4. Saiyitijiang A, Aizezi M, Zhao Y, Gao Y (2022) Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta-analysis. Ann Noninvasive Electrocardiol 27(5):e12977. https://doi.org/10.1111/anec.12977

5. MacCarthy EP, Bloomfield SS (1983) Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 3(4):193–219. https://doi.org/10.1002/j.1875-9114.1983.tb03252.x

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal relationship between the gut microbiota, immune cells, and coronary heart disease: a mediated Mendelian randomization analysis;Frontiers in Microbiology;2024-08-05

2. Metagenomic analysis revealed the association between gut microbiota and different ovary responses to controlled ovarian stimulation;Scientific Reports;2024-06-28

3. Gut Microbiota and Its Metabolites: The Emerging Bridge Between Coronary Artery Disease and Anxiety and Depression?;aging and disease;2024